OpenEvidence adds FDA-cleared heart disease AI
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- OpenEvidence will add an FDA-cleared AI tool designed to detect heart disease from EKGs, according to STAT's Health Tech newsletter.
- Pierre Elias, a researcher named to STAT's Wunderkinds list in 2020, developed the AI and is pursuing plans to commercialize it.
Why it matters: The integration moves an FDA-cleared EKG-based heart disease detection tool onto an established medical AI platform, potentially accelerating its reach into clinical workflows where cardiologists read EKGs.
